Furthermore, to assess the effect of putative alteration of d-Asp metabolism in the human brain, another study reported the association among DDO gene variations, prefrontal DDO mRNA expression and structural/functional prefrontal phenotypes relevant to schizophrenia (80). This evidence concerns the gene DDO and schizophrenia.